A Study of OVV-01 Injection in Combination With IBR900 Cell Injection in Patients With Advanced Malignant Tumors

Clinical trial NCT05271279 · TERMINATED

Trial details

NCT number: NCT05271279
Sponsor: Beijing Boren Hospital
Status: TERMINATED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Relapsed/Refractory Lymphoma

Start date: 2021-12-24
Primary completion: 2022-08-29
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.